Treatment and rehabilitation of Long COVID:A scope of the literature. Update July 2024

We identified 19 randomised controlled trials published between March and June 2024 that were focused on Long COVID treatment or rehabilitation. Across our nine reports produced to date, we have identified and assessed 140 trials published between January 2022 and June 2024. • Eight of the 19 trials focused on treating generalised or multiple symptoms of Long COVID. Four trials focused specifically on respiratory or cardiovascular function or physical fitness. Four other trials focused solely on treating persistent problems with the sense of smell or taste (olfactory/gustatory dysfunction) and three trials evaluated treatments for fatigue. • Two trials were rated positively for 10 out of the 13 quality criteria that we assessed. The other 17 trials gained a positive rating for between four and nine criteria.